Author

THAMIL ANNAMALAI 1

1 PROTAGONIST THERAPEUTICS, Milpitas, United States of America

SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL ORAL PEPTIDE THERAPEUTIC PTG-100 (ALPHA4-BETA7 INTEGRIN ANTAGONIST) IN NORMAL HEALTHY VOLUNTEERS

Richard Shames, Lucio Tozzi, Larry Mattheakis, THAMIL ANNAMALAI, ASHOK BHANDARI, David Liu

Safety, Tolerability, and Pharmacokinetics of PTG-200, An Oral GI-restricted Peptide Antagonist of IL-23 Receptor, In Normal Healthy Volunteers

Lili Xiaoli Cheng, Tien-Yi Lee, Grace Ledet, James Tovera, Robert Campbell, Norbert Purro, THAMIL ANNAMALAI, ASHOK BHANDARI, Mohammad Masjedizadeh, David Liu, Roya Nawabi, Bittoo Kenwar

Item 1 - 2 / 2
1